Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker

Triggering receptor expressed on myeloid cells-2 (TREM2) is a transmembrane receptor of the immunoglobulin superfamily and a crucial signaling hub for multiple pathological pathways that mediate immunity. Although increasing evidence supports a vital role for TREM2 in tumorigenesis of some cancers,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xin, Wang, Xiaowei, Nie, Kechao, Cheng, Lin, Zhang, Zheyu, Hu, Yang, Peng, Weijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925850/
https://www.ncbi.nlm.nih.gov/pubmed/33679809
http://dx.doi.org/10.3389/fimmu.2021.646523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925850/
https://www.ncbi.nlm.nih.gov/pubmed/33679809
http://dx.doi.org/10.3389/fimmu.2021.646523

Ejemplares similares